Dr. Andreas Rimner, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
16 drugs studied
Area of expertise
1Lung Cancer
Stage III
Stage IV
Stage II
2Non-Small Cell Lung Cancer
Stage III
Stage II
Stage I
Affiliated Hospitals
Clinical Trials Andreas Rimner, MD is currently running
Durvalumab + Radiation
for Lung Cancer
This trial is testing whether combining the drug durvalumab with a precise radiation treatment is more effective for early-stage lung cancer patients than using the radiation treatment alone. Durvalumab has shown promise in improving survival rates in advanced lung cancer patients and is being tested in various combinations, including with radiation therapy.
Recruiting1 award Phase 211 criteria
Pembrolizumab + Radiation
for Mesothelioma
The purpose of this study is to find out whether IMPRINT in combination with pembrolizumab is a safe treatment for people with malignant pleural mesothelioma (MPM).The highest dose of IMPRINT that causes few or mild side effects when given in combination with pembrolizumab will be found. Once the highest safe dose of IMPRINT is found, it will be tested in combination with pembrolizumab in future participants to see whether the combination may be an effective treatment for MPM.
Recruiting1 award Phase 1
More about Andreas Rimner, MD
Clinical Trial Related3 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Andreas Rimner, MD has experience with
- Durvalumab
- Stereotactic Body Radiation Therapy
- Pembrolizumab
- IMPRINT
- Calypso-based Deep Inspiration Breath Hold (DIBH) Radiation Treatments
- Pemetrexed
Breakdown of trials Andreas Rimner, MD has run
Lung Cancer
Non-Small Cell Lung Cancer
Malignant Pleural Mesothelioma
Mesothelioma
PD-L1 Mutation
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andreas Rimner, MD specialize in?
Andreas Rimner, MD focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage III patients, or patients who are Stage IV.
Is Andreas Rimner, MD currently recruiting for clinical trials?
Yes, Andreas Rimner, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Andreas Rimner, MD has studied deeply?
Yes, Andreas Rimner, MD has studied treatments such as Durvalumab, Stereotactic Body Radiation Therapy, Pembrolizumab.
What is the best way to schedule an appointment with Andreas Rimner, MD?
Apply for one of the trials that Andreas Rimner, MD is conducting.
What is the office address of Andreas Rimner, MD?
The office of Andreas Rimner, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.